Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure

Martine Blanchet(Montreal Heart Institute), Michel White(Montreal Heart Institute), Normand Racine(Montreal Heart Institute), Richard Sheppard(Jewish General Hospital), Jacques de Champlain(Université de Montréal), Pierré Sirois(Université Laval), Daniel Curnier(Montreal Heart Institute), Marie-Catherine Lamoureux(Montreal Heart Institute), Jean‐Claude Tardif(Montreal Heart Institute), Anique Ducharme(Montreal Heart Institute)
American Heart Journal
May 1, 2005
10.1016/j.ahj.2004.11.011
Cited by 17

Related Papers

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
|New England Journal of Medicine|2015|2.3k
Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis
|JAMA|2006|2k
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2012|2k
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
|New England Journal of Medicine|2008|1.6k